Cost-effectiveness of various tuberculosis control strategies in Thailand

Value in Health

Volumn 15, Issue 1 SUPPL., 2012, Pages

  Hunchangsith, Pojjana ^a,b   Barendregt, Jan J ^c   Vos, Theo ^b,c   Bertram, Melanie ^b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

cost effectiveness; DOT; mobile phone reminder; self administered treatment; Thailand; tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

COMMUNITY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIRECTLY OBSERVED THERAPY; DISABILITY; DISEASE MODEL; DRUG SELF ADMINISTRATION; HEALTH CARE PERSONNEL; HEALTH INSURANCE; HUMAN; INFECTION CONTROL; LUNG TUBERCULOSIS; MOBILE PHONE; MORTALITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SPUTUM SMEAR; THAILAND; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTITUBERCULAR AGENTS; CELLULAR PHONE; COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; HUMANS; REMINDER SYSTEMS; THAILAND; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84856016513     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.11.006     Document Type: Conference Paper

References (35)

1. World Health Organization Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009 WHO/HTM/TB/2009.411 2009 World Health Organization Geneva
2. World Health Organization What Is DOTS? A Guide to Understanding the WHO-Recommended TB Control Strategy Known as DOTS WHO/CDS/CPC/TB/99.270 1999 World Health Organization Geneva
3. P. Pungrassami, S.P. Johnsen, V. Chongsuvivatwong Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers Int J Tuberc Lung Dis 6 2002 389 395 (Pubitemid 34492162)
4. World Health Organization Treatment of Tuberculosis: Guidelines WHO/HTM/TB/2009.420 2009 World Health Organization Geneva
5. M.A. Khan, J.D. Walley, S.N. Witter Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan Health Pol Plan 17 2002 178 186 (Pubitemid 34587121)
6. C.I. Mohan, D. Bishai, S. Cavalcante, R.E. Chaisson The cost-effectiveness of DOTS in urban Brazil Int J Tuberc Lung Dis 11 2007 27 32 (Pubitemid 46101842)
7. J. Volmink, P. Garner Directly observed therapy for treating tuberculosis Cochrane Database Syst Rev 2007 Issue 4:Art. No. CD003343
8. P. Kamolratanakul, H. Sawert, S. Lertmaharit Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand Trans R Soc Trop Med Hyg 93 1999 552 557 (Pubitemid 29495849)
9. Vital Wave Consulting mHealth for Development: The Opportunity of Mobile Technology for Healthcare in the Developing World 2009 UN Foundation-Vodafone Foundation Partnership Washington, DC, and Berkshire
10. W.A. Kaplan Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Global Health 2 2006 9
11. J. DeMaio, L. Schwartz, P. Cooley, A. Tice The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project Clin Infect Dis 33 2001 2082 2084 (Pubitemid 33152408)
12. S. Visrutaratna, K. Sawadee, P. Thachorn, A. Norchaiwong Mobile phone monitoring care: a new approach to improve tuberculosis treatment adherence J Public Health Dev 6 2008 43 50
13. Bureau of Tuberculosis Management of Tuberculosis: Modified WHO Modules of Managing Tuberculosis at District Level 2005 Bureau of Tuberculosis Nonthaburi, Thailand
14. Bureau of Tuberculosis National Guidelines for Multi-Drug Resistant Tuberculosis (MDR-TB) Treatment 2005 Bureau of Tuberculosis Nonthaburi, Thailand
15. A. Harries What are the current recommendations for standard regimens? T. Frieden, Toman's Tuberculosis Case Detection, Treatment, and Monitoring: Questions and Answers (2nd ed.) 2004 World Health Organization Geneva
16. Bureau of Tuberculosis Report on New Tuberculosis Patients, Re-Treatment Patients Registered in Fiscal Year 2006 and Their Treatment Outcomes 2006 Bureau of Tuberculosis Nonthaburi, Thailand
17. W. Reechaipichitkul Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand Southeast Asian J Trop Med Public Health 33 2002 570 574
18. Bureau of Tuberculosis Report on New Tuberculosis Patients Registered in Fiscal Year 2005 2005 Bureau of Tuberculosis Nonthaburi, Thailand
19. S. Jittimanee, J. Vorasingha, W. Mad-asin Tuberculosis in Thailand: epidemiology and program performance, 20012005 Int J Infect Dis 13 2009 436 442
20. J.K. Varma, D. Wiriyakitjar, S. Nateniyom Evaluating the potential impact of the new Global Plan to Stop TB: Thailand, 20042005 Bull World Health Organ 85 2007 586 592 (Pubitemid 47328201)
21. R. Baltussen, T. Adam, T. Tan-Torres Edejer Methods for generalized cost-effectiveness analysis T. Tan-Torres Edejer, R. Baltussen, T. Adam, Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis 2003 World Health Organization Geneva
22. C.D. Mathers, J.A. Salomon, C.J.L. Murray, A.D. Lopez Alternative summary measures of average population health C.J.L. Murray, D.B. Evans, Health Systems Performance Assessment: Debates, Methods and Empiricism 2003 World Health Organization Geneva
23. Y. Porapakkham, C. Rao, J. Pattaraarchachai Estimated causes of death in Thailand, 2005: implications for health policy Popul Health Metr 8 2010 14
24. C. Rao, Y. Porapakkham, J. Pattaraarchachai Verifying causes of death in Thailand: rationale and methods for empirical investigation Popul Health Metr 8 2010 11
25. J. Pattaraarchachai, C. Rao, W. Polprasert Cause-specific mortality patterns among hospital deaths in Thailand: validating routine death certification Popul Health Metr 8 2010 12
26. W. Polprasert, C. Rao, T. Adair Cause-of-death ascertainment for deaths that occur outside hospitals in Thailand: application of verbal autopsy methods Popul Health Metr 8 2010 13
27. M.E. Stouthard, M.-L. Essink-Bot, G.J. Bonsel Disability Weights for Disease in the Netherlands 1997 Department of Public Health, Erasmus University Rotterdam Rotterdam, The Netherlands
28. The Thai Working Group on Burden of Disease and Injuries Burden of Disease and Injuries in Thailand 2002 Ministry of Public Health Nonthaburi, Thailand
29. D.B. Evans, T. Tan-Torres Edejer, T. Adam, S.S. Lim Methods to assess the costs and health effects of interventions for improving health in developing countries BMJ 331 2005 1137 1140
30. World Health Organization Purchasing power parity 2005 http://www.who.int/choice/costs/ppp/en/ [Accessed August 4, 2009]
31. World Health Organization Cost-effectiveness thresholds http://www.who.int/choice/costs/CER-thresholds/en/index.html [Accessed December 14, 2009]
32. National Tuberculosis Institute Tuberculosis in a rural population of South India: a five-year epidemiological study Bull World Health Organ 51 1974 473 488
33. J.J. Barendregt Ersatz User Guide 2009 EpiGear International Pty Ltd. Brisbane http://www.epigear.com/index-files/Ersatz%20User%20Guide.pdf [Accessed November 29, 2011]
34. J.D. Walley, M.A. Khan, J.N. Newell, M.H. Khan Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan Lancet 357 2001 664 669 (Pubitemid 32206424)
35. I.D. Rusen, N. At-Khaled, E. Alarcn Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcome Int J Tuberc Lung Dis 11 2007 120 121 (Pubitemid 46219272)